---
title: "OrthoBio Market: SmartTRAK Predicts strong Growth Ahead"
description: Robust growth is predicted for the US OrthoBio market driving revenues to over $4B by 2021E according to SmartTRAK projections.
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [OrthoBio Market: SmartTRAK Predicts strong Growth Ahead](https://blog.smarttrak.com/orthobio-solid-growth-ahead)

 Written by [Sharon O'Reilly](https://blog.smarttrak.com/author/sharon-oreilly) | 8/24/17 10:50 PM

**Robust growth is predicted for the US OrthoBio market, driving revenu****es to over $4B by 2021E according to Smart****TRAK projections.**

- Bone Replacement remains the largest segment of the US
- Bone Replacement remains the largest segment of the US OrthoBio market, accounting for over 50% of total 2016 revenues, followed by Joint Fluid at nearly 30% based on 2016 SmartTRAK Financial Dashboard results.  Next in line are Knee Ligament Grafts, Cartilage, Soft Tissue and Meniscus replacement which account for the remainder...

- Going forward, technologies for Cartilage and Meniscal Replacement will experience the greatest growth over the forecast period as new technologies make their way through the FDA process.
- Mature segments such as Bone Replacement and Knee Ligament Grafts will see CAGRs in the ~3.0%+ range while Soft Tissue Augmentation and Joint Fluid will be in the neighborhood of ~5.0%, based on **SmartTRAK** projections.
- New premium priced products (Stem cells, Cellular based, Growth factors) will fuel expansion of the US Bone Replacement Market, to over $2B by 2021E.
- With several new technologies in FDA trials, the US Cartilage Replacement Market (for knee and ankle indications) is projected at to reach over $200MM by 2021E
- Recently launched synthetic technologies for partial meniscal replacement, along with introduction of prosthetic implants for total replacement in the 2018-2019 timeframe, will reinvigorate the US Meniscus Replacement Market, comprised today solely of allograft transplants.
- Composed of products used for reinforcing or augmenting orthopedic tissues, the US Soft Tissue Augmentation Market will reach over $100MM in 2021E.
- The US market for Knee Ligament Replacement, consisting of Tendon Allografts, is projected to exceed $220.5MM in 2021E.
- The US Joint Fluid Replacement Market will be driven by continued adoption of higher-priced single injection products, expanding indications and the launch of new, novel products that provide longer-lasting pain relief.
- On the competitive front, the top five contenders in the 2016 US OrthoBio Market include: Medtronic, leading player; followed by Depuy Synthes; joint fluid supplier Sanofi; Zimmer Biomet and Ferring, according to **SmartTRAK** Financial Dashboard results. With over 250 companies participating in this field, it is not surprising that the “Other” category accounts for more than 40% of total OrthoBio revenues in 2016. 

 

 

[View full post](https://blog.smarttrak.com/orthobio-solid-growth-ahead)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Sharon O'Reilly"
  },
  "dateModified" : "2017-08-31T19:01:21.140Z",
  "datePublished" : "2017-08-24T22:50:48Z",
  "headline" : "OrthoBio Market: SmartTRAK Predicts strong Growth Ahead",
  "image" : {
    "@type" : "ImageObject",
    "height" : 797,
    "url" : "https://cdn2.hubspot.net/hubfs/3044256/OrthoBio.png",
    "width" : 1200
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/orthobio-solid-growth-ahead",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```